Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  fluorine F 18 fluciclovine
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Anti-Fluorine F 18 Fluciclovine Positron Emission Tomography-Computed Tomography Radiation Therapy Planning in Treating Men with Prostate Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 to 95
Trial IDs: CA16918801, NCI-2012-02088, IRB00057680, NCT01666808
Radium Ra 223 Dichloride in Treating Patients with Metastatic Castration-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-375, NCI-2015-00625, ONC-2013-119, NCT02346526
Fluciclovine (18F) PET/CT Imaging in Indicating Early Metastatic Disease in Patients with High or Unfavorable Intermediate-Risk Prostate Cancer
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: EU3330-16, NCI-2017-00251, IRB00092595, NCT03081884
Fluorine F 18 Fluciclovine PET/CT in Imaging Patients with Parathyroid Cancer Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: PTHA, NCI-2014-02135, IRB00051415, NCT01574287
Fluciclovine (18F) PET/CT in Imaging Patients with Head and Neck Squamous Cell Carcinoma
Status: Temporarily closed
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: RAD2424-13, NCI-2014-02665, IRB00062214, NCT01933269
FACBC PET and Transrectal Ultrasound-Guided Biopsy in Detecting Recurrence after Definitive Therapy in Patients with Prostate Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: RAD2941-15, NCI-2017-00523, IRB00080287, NCT02744534
Start Over